ALPEK, S.A.B. de C.V. (FRA:27A)
Germany · Delayed Price · Currency is EUR | Market Cap | 1.55B +68.2% |
| Revenue (ttm) | 6.49B -0.7% |
| Net Income | 189.63M |
| EPS | 0.09 |
| Shares Out | n/a |
| PE Ratio | 8.42 |
| Forward PE | 8.32 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 100 |
| Open | 0.7450 |
| Previous Close | 0.7900 |
| Day's Range | 0.7450 - 0.7450 |
| 52-Week Range | 0.3620 - 0.7900 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 21, 2026 |
About ALPEK
ALPEK, S.A.B. de C.V., together with its subsidiaries, operates as a petrochemical company in Mexico, the United States, Argentina, Brazil, Chile, Canada, the United Kingdom, Oman, and Saudi Arabia. It operates in two segments, Polyester, and Plastic and Chemicals. The company offers purified terephthalic acid (PTA), an organic compound that is raw material for PET; polyethylene terephthalate (PET), a plastic resin that creates products for their lightness, hygiene, and resistance along with their recyclability; recycled PET for new bottles and... [Read more]
Financial Performance
In 2025, ALPEK's revenue was 126.84 billion, a decrease of -7.69% compared to the previous year's 137.41 billion. Losses were -2.77 billion, 262.6% more than in 2024.
Financial numbers in MXN Financial StatementsNews
ALPEK Earnings Call Transcript: Q3 2026
Q3 comparable EBITDA doubled YoY to $276 million, prompting a 2026 guidance increase to $990 million. Leverage improved to 1.8x, while high working-capital investment weighed on cash flow; management expects spreads and freight to ease but remain supportive.
ALPEK Earnings release: Q3 2026
ALPEK released its Q3 2026 earnings on October 22, 2026, summarizing the period's financial results.
ALPEK Slides: Q3 2026
ALPEK has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on October 22, 2026.
Alpek upgraded to Outperform from Market Perform at BBVA
BBVA upgraded Alpek (ALPKF) to Outperform from Market Perform with a MXN 16 price target
ALPEK Earnings Call Transcript: Q2 2026
Strong operational execution and supply chain agility drove a 169% year-over-year EBITDA increase and improved leverage, prompting a raised 2026 guidance. Elevated PET margins and freight rates are expected to normalize but remain above prior forecasts, with no dividend resumption planned.
ALPEK Earnings release: Q2 2026
ALPEK released its Q2 2026 earnings on July 23, 2026, summarizing the period's financial results.
ALPEK Slides: Q2 2026
ALPEK has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 23, 2026.
ALPEK Slides: Institutional presentation
ALPEK has posted slides in relation to its latest quarterly earnings report, which was published on July 5, 2026.
Alpek upgraded to Overweight from Neutral at JPMorgan
JPMorgan upgraded Alpek (ALPKF) to Overweight from Neutral with a price target of MXN 18, up from MXN 15. The firm names Alpek its top pick in Latin America petrochemicals.
ALPEK Slides: Institutional presentation
ALPEK has posted slides in relation to its latest quarterly earnings report, which was published on April 29, 2026.
Alpek upgraded to Outperform from Sector Perform at Scotiabank
Scotiabank analyst Ben Isaacson upgraded Alpek (ALPKF) to Outperform from Sector Perform with a price target of MXN 15, up from MXN 12.50. The firm sees the company as benefitting…
ALPEK Earnings Call Transcript: Q1 2026
Q1 saw a 50% sequential EBITDA increase, driven by strong execution, asset optimization, and favorable market conditions amid geopolitical disruptions. Guidance for Q2 is robust, with further asset sales and specialty product investments expected to enhance margins.
ALPEK Earnings release: Q1 2026
ALPEK released its Q1 2026 earnings on April 23, 2026, summarizing the period's financial results.
ALPEK Slides: Q1 2026
ALPEK has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 23, 2026.
Alpek downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley downgraded Alpek (ALPKF) to Equal Weight from Overweight with a price target of MXN 10, down from MXN 14. The firm notes that while it continues to like…
ALPEK Earnings Call Transcript: Q4 2025
2025 results were impacted by global overcapacity and weak polyester margins, but operating free cash flow improved 57% year-over-year. 2026 guidance projects comparable EBITDA of $450–$500 million, with deleveraging and asset sales as top priorities.
ALPEK Earnings release: Q4 2025
ALPEK released its Q4 2025 earnings on February 11, 2026, summarizing the period's financial results.
ALPEK Slides: Q4 2025
ALPEK has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 11, 2026.
ALPEK Annual report: Q4 2025
ALPEK has published its Q4 2025 annual report on February 11, 2026.
Alpek downgraded to Market Perform from Outperform at BBVA
BBVA downgraded Alpek (ALPKF) to Market Perform from Outperform with a MXN 11.60 price target
ALPEK Earnings Call Transcript: Q3 2025
Sequential EBITDA and cash flow improved, but full-year guidance was revised down due to persistent oversupply, low margins, and heavy imports. Merger approval and new U.S. tariffs on PET are expected to benefit results from 2026.
ALPEK Earnings release: Q3 2025
ALPEK released its Q3 2025 earnings on October 22, 2025, summarizing the period's financial results.
ALPEK Slides: Q3 2025
ALPEK has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 22, 2025.
Alpek upgraded to Outperform from Neutral at Grupo Santander
Grupo Santander upgraded Alpek (ALPKF) to Outperform from Neutral with a MXN 15.50 price target
ALPEK Earnings Call Transcript: Q2 2025
Second quarter results showed resilient plastics and chemicals performance offsetting polyester margin pressure from global oversupply and tariffs. Guidance was revised lower, with a focus on cost control, asset optimization, and financial flexibility.